With their Nobel Prize winning research, Allison and Honjo argued for a new approach to cancer therapy with very promising outcomes using the inhibition of negative immune regulation by inhibiting the CTLA4 and PD1 immune checkpoints that allow T cells to eradicate cancer cells [145]. This evidence concerns the gene PDCD1 and cancer.